Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering.
In the wake of the COVID-19 pandemic, the market for point-of-care testing (POCT) of respiratory infections has witnessed unprecedented growth, sparking intense competition for market share. This growth isn't limited to COVID-19 diagnostics alone; it encompasses screenings for over 20 different respiratory pathogens. The evolution in testing methodology, whether employing multiplex or single-plex diagnostics, highlights a dynamic and rapidly shifting landscape as competitors position themselves in largely uncharted territories.
Advancements in technology are revolutionizing respiratory infection diagnostics by significantly reducing the time to result, thus expanding the market far beyond the existing microbiology-based practices. This shift has effectively integrated laboratory capabilities into emergency room settings, aligning with the urgent need for rapid diagnostics.
The prevalent nature of respiratory infections, with some demographics experiencing up to eight colds annually, underscores the enormous potential market size. Exemplifying this potential, the respiratory sector is already the largest infectious disease category and is poised for exponential growth. This scenario presents a substantial growth opportunity for diagnostic companies eager to capitalize on the expanding demand.
For businesses poised to navigate this lucrative landscape, understanding the opportunities and inherent risks is crucial. An in-depth report provides comprehensive insights, equipping decision-makers with the knowledge required to exploit market dynamics effectively. This report serves as a valuable resource, ensuring that professionals attain an expert-level understanding, bolstered by additional specific data and assistance offered at no extra cost.
Armed with the latest data, businesses can confidently make informed investment decisions and accurate valuations. This combination of knowledge and resources ensures a competitive edge, enabling companies to thrive in a burgeoning market driven by technological innovation and growing demand.
Key Topics Covered
1 Market Guides
- 1.1 Situation Analysis
 - 1.2 Guide for Executives and Business Development Staff
 - 1.3 Guide for Management Consultants and Investment Advisors
 
2 Introduction and Market Definition
- 2.1 What are Respiratory Infections?
 - 2.2 The Role of Diagnosis & Treatment
 - 2.3 Market Definition
 - 2.4 Methodology
 - 2.5 Perspective: Healthcare and the IVD Industry
 
3 Market Overview
- 3.1 Players in a Dynamic Market
 - 3.2 Respiratory Infections
 - 3.3 Diagnostics - A Changing Role
 - 3.4 COVID-19
 - 3.5 Pandemic Diagnostics
 
4 Market Trends
- 4.1 Factors Driving Growth
 - 4.2 Factors Limiting Growth
 - 4.3 Instrumentation and Automation
 - 4.4 Diagnostic Technology Development
 
5 Respiratory Infection Diagnostics Recent Developments
- 5.1 Recent Developments - Importance and How to Use This Section
 - 5.2 Qiagen Respiratory Mini Panel Approved
 - 5.3 Co-Diagnostics Submits At-Home PCR System to FDA
 - 5.4 AMDI scores $5.3m NIH grant for Rapid POC Panel
 
6 Profiles of Key Players
- 6.1 Abacus Diagnostica
 - 6.2 Abbott Laboratories
 - 6.3 Accelerate Diagnostics
 
7 The Global Market for Respiratory Infection Diagnostics
- 7.1 Global Market by Country
 - 7.2 Global Market by Technology - Overview
 - 7.3 Global Market by Plex - Overview
 - 7.4 Global Market by Place - Overview
 - 7.5 Global Market by Product - Overview
 
8 Global Respiratory Infection Diagnostic Markets - By Technology
- 8.1 Microbiology
 - 8.2 PCR
 - 8.3 NGS
 - 8.4 Immunoassay/Other
 
9 Global Respiratory Infection Diagnostic Markets - by Plex
- 9.1 C19 Single Plex
 - 9.2 Singleplex
 - 9.3 Duplex/Triplex
 - 9.4 Multiplex Technology
 
10 Global Respiratory Infection Diagnostic Markets - by Place
- 10.1 Hospital Lab
 - 10.2 Outpatient Lab
 - 10.3 POC
 - 10.4 Other Technology
 
11 Global Respiratory Infection Diagnostic Markets - by Product
- 11.1 Instruments
 - 11.2 Consumables
 - 11.3 Software & Service
 
12 Appendices
- 12.1 United States Medicare System: Clinical Laboratory Fees Schedule
 - 12.2 The Most Used IVD Assays
 - 12.3 The Highest Grossing Assays
 
Companies Featured
- 3EO Health
 - Abacus Diagnostica
 - Abbott Laboratories
 - Accelerate Diagnostics
 - Access Bio
 - Ador Diagnostics
 - ADT Biotech
 - Akonni Biosystems
 - Altona Diagnostics
 - Alveo Technologies
 - AMDI
 - Anatolia Geneworks
 - Angstrom Bio
 - Antelope Dx
 - Applied BioCode
 - Aptitude Medical Systems
 - Assurance Scientific Laboratories
 - Aureum Diagnostics
 - Aus Diagnostics
 - BD (Becton Dickinson and Company)
 - Beckman Coulter Diagnostics
 - Becton Dickinson (BD)
 - BforCure
 - Binx Health
 - Bio-Rad Laboratories
 - Biocartis
 - BioExcel Diagnostics
 - BioFire Diagnostics (bioMerieux)
 - BioMerieux
 - Bosch Healthcare Solutions
 - Celemics
 - Cepheid (Danaher)
 - Chembio
 - Co-Diagnostics
 - Credo Diagnostics Biomedical
 - Cue Health
 - Curetis N.V./GmbH
 - Delve Bio
 - Detect
 - Diagenode Diagnostics
 - Diagnostics for the Real World
 - Diasorin S.p.A.
 - Eurofins Scientific
 - Fluxergy
 - Fulgent Genetics
 - Fusion Genomics
 - Gemina Labs
 - Genetic Signatures
 - GenMark
 - Genomtec
 - Hibergene Diagnostics
 - Hologic
 - Immunexpress
 - Invetech
 - Janssen Diagnostics
 - Karius
 - Lexagene
 - LGC
 - LightDeck Diagnostics
 - Luminex
 - Lumos Diagnostics
 - Mammoth Biosciences
 - Mesa Biotech (Thermo Fisher)
 - Millipore Sigma
 - Mindray
 - MiRxes
 - Mobidiag (Hologic)
 - Nanomix
 - Ortho Clinical Diagnostics
 - Oxford Nanopore Technologies
 - Panagene
 - PerkinElmer
 - Prenetics
 - Primerdesign (Novacyt)
 - Prominex
 - ProtonDx
 - Qiagen
 - QuantuMDx
 - QuidelOrtho
 - ReadyGo Diagnostics
 - Roche
 - SD Biosensor
 - Seegene
 - Sense Biodetection
 - Sensible Diagnostics
 - Senzo
 - Siemens Healthineers
 - Sona Nanotech
 - SpeeDx
 - T2 Biosystems
 - Takara Bio USA
 - Talis Biomedical
 - Tempus
 - Thermo Fisher Scientific
 - Veramarx
 - Veredus Laboratories
 - Visby Medical
 - XCR Diagnostics
 - Zhejiang Orient Gene Biotech
 
For more information about this report visit https://www.researchandmarkets.com/r/g2h4gt
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.